State Directory
Provider Records in Ohio
GLP1Search tracks 343 provider records across 91 Ohio cities. 11 records include explicit GLP-1, medication, or peptide treatment evidence; 332 are directory-only healthcare/provider records that need direct confirmation.
Provider Records
343
Cities
91
Treatment Evidence
11
Directory-Only
332
Market Snapshot
Where source-ready GLP-1 records are concentrated in Ohio
The Ohio source-ready local index is led by Columbus. Across the state, 97% of provider records include phone plus address or website coverage, 0% list public pricing, and 41% carry an upstream source/place signal.
Data Complete
97%
Pricing Visible
0%
Source Flagged
41%
Treatment-Specific Directories
Medication and peptide location pages for Ohio
These pages focus on high-intent treatment searches where the state has enough listing density to support a useful directory page.
Top Ohio cities for source-ready GLP-1 records
Featured provider records in Ohio
Ivím HealthColumbus · Contact for PricingTirzepatide evidenceOhio Men's HealthColumbus · Contact for PricingSemaglutide evidenceGameday Men's HealthColumbus · Starting at $199/month; Free testosterone testing; No contractsSemaglutide, Tirzepatide, TRTPro Health Services - Columbus's Premier Weight Loss And Hormone Balancing CenterColumbus · Contact for PricingSemaglutide evidence, Tirzepatide evidenceForever Weight Loss, LLCColumbus · Contact for PricingSemaglutide evidence, Tirzepatide evidenceRetro Health and AestheticsColumbus · Contact for PricingSemaglutide evidence, Tirzepatide evidence
All covered cities in Ohio
Questions about provider records in Ohio
How many providers are listed?
GLP1Search lists 343 provider records across 91 cities in Ohio, including 11 treatment-evidence records and 332 directory-only records to verify.
Which cities have the most listings?
Columbus (97), Dublin (20), Powell (13), Cincinnati (11), Westerville (10) currently have the highest listing density in Ohio.
What should patients compare?
Compare licensed clinical oversight, medication source, pharmacy type, public pricing, follow-up cadence, side-effect support, and whether the clinic documents semaglutide or tirzepatide availability.